Jiangxi Fushine Pharmaceutical Co., Ltd. (SHE:300497)
China · Delayed Price · Currency is CNY 17.32
-0.04 (-0.23%)
Aug 21, 2026, 3:04 PM CST
SHE:300497 Market Cap
SHE:300497 has a market cap or net worth of 9.33 billion as of August 21, 2026. Its market cap has increased by 66.70% in one year.
Market Cap
9.33B
Enterprise Value
10.45B
Revenue
1.56B
Ranking
n/a
PE Ratio
63.56
Stock Price
17.32
ChartMarket Cap Chart
Since December 22, 2015, SHE:300497's market cap has increased from 1.59B to 9.33B, an increase of 486.84%. That is a compound annual growth rate of 18.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 9.33B | 14.63% |
| Dec 31, 2025 | 8.14B | 81.18% |
| Dec 31, 2024 | 4.49B | -10.90% |
| Dec 29, 2023 | 5.04B | -29.09% |
| Dec 30, 2022 | 7.11B | -19.99% |
| Dec 31, 2021 | 8.89B | 34.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hualan Biological Vaccine | 10.62B |
| Pacific Shuanglin Bio-pharmacy | 10.49B |
| Vcanbio Cell & Gene Engineering Corp., | 9.61B |
| Chongqing Genrix Biopharmaceutical | 9.52B |
| Beijing Hotgen Biotech | 9.37B |
| Bio-Thera Solutions | 9.01B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 8.91B |
| Shanghai OPM Biosciences | 8.90B |